BCAL Diagnostics Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

BCAL Diagnostics has a total shareholder equity of A$8.6M and total debt of A$641.3K, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are A$12.3M and A$3.7M respectively.

Anahtar bilgiler

7.5%

Borç/özkaynak oranı

AU$641.34k

Borç

Faiz karşılama oranın/a
NakitAU$6.47m
EşitlikAU$8.59m
Toplam yükümlülüklerAU$3.68m
Toplam varlıklarAU$12.27m

Son finansal sağlık güncellemeleri

Recent updates

Is BCAL Diagnostics (ASX:BDX) In A Good Position To Deliver On Growth Plans?

Aug 08
Is BCAL Diagnostics (ASX:BDX) In A Good Position To Deliver On Growth Plans?

Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Apr 07
Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

Dec 23
Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BDX's short term assets (A$9.3M) exceed its short term liabilities (A$2.6M).

Uzun Vadeli Yükümlülükler: BDX's short term assets (A$9.3M) exceed its long term liabilities (A$1.1M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BDX has more cash than its total debt.

Borcun Azaltılması: BDX's debt to equity ratio has increased from 0% to 7.5% over the past 5 years.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: BDX has sufficient cash runway for more than a year based on its current free cash flow.

Tahmini Nakit Akışı: BDX is forecast to have sufficient cash runway for 12 months based on free cash flow estimates, but has since raised additional capital.


Sağlıklı şirketleri keşfedin